A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin ...

Brain hemorrhage cases are rising among youngsters aged 25-35 due to factors like high blood pressure, head trauma, and ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

Significantly more patients with acute ischemic stroke achieved primary outcome of 0 or 1 on modified Rankin scale at 90 days ...

A new tool that uses information found in patients’ medical records could predict risk for intracranial hemorrhage in ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Some clinicians prefer aspirin when balancing bleeding risk with the indication for an anticoagulant, Barnes said, reasoning ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...